CRISPR and CRISPR-associated (Cas) Genes Market Report

Global and Region CRISPR and CRISPR-associated (Cas) Genes Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：177
  • REPORT CODE：GMM1013674
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of CRISPR and CRISPR-associated (Cas) Genes market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of CRISPR and CRISPR-associated (Cas) Genesmarket, defines the market attractiveness level of CRISPR and CRISPR-associated (Cas) Genes market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of CRISPR and CRISPR-associated (Cas) Genes industry, describes the types of CRISPR and CRISPR-associated (Cas) Genes market, the applications of major players and the market size, and deeply analyzes the current situation of the global CRISPR and CRISPR-associated (Cas) Genes market and the development prospects and opportunities of CRISPR and CRISPR-associated (Cas) Genes industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CRISPR and CRISPR-associated (Cas) Genes market in Chapter 13.

    By Player:

    • Editas Medicine

    • GE Healthcare Dharmacon

    • Thermo Fisher Scientific

    • Caribou Biosciences

    • CRISPR THERAPEUTICS

    • Mirus Bio LLC

    • Addgene

    • Takara Bio USA

    • Merck KGaA

    • Horizon Discovery Group

    • Intellia Therapeutics

    By Type:

    • Genome Editing

    • Genetic Engineering

    • gRNA Database/Gene Librar

    • CRISPR Plasmid

    • Human Stem Cells

    • Genetically Modified Organisms/Crops

    • Cell Line Engineering

    By End-User:

    • Biotechnology Companies

    • Pharmaceutical Companies

    • Academic Institutes

    • Research and Development Institutes

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 CRISPR and CRISPR-associated (Cas) Genes Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 CRISPR and CRISPR-associated (Cas) Genes Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 CRISPR and CRISPR-associated (Cas) Genes Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 CRISPR and CRISPR-associated (Cas) Genes Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise CRISPR and CRISPR-associated (Cas) Genes Market Analysis and Outlook to 2022

    • 7.1 Global CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    • 7.2 United States CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    • 7.3 Europe CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    • 7.4 China CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    • 7.5 Japan CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    • 7.6 India CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    • 7.7 South Korea CRISPR and CRISPR-associated (Cas) Genes Consumption (2017-2022)

    8 Region and Country-wise CRISPR and CRISPR-associated (Cas) Genes Market Analysis and Outlook to 2028

    • 8.1 Global CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    • 8.2 United States CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    • 8.3 Europe CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    • 8.4 China CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    • 8.5 Japan CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    • 8.6 India CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    • 8.7 South Korea CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast (2022-2028)

    9 Global CRISPR and CRISPR-associated (Cas) Genes Market Outlook by Types and Applications to 2022

    • 9.1 Global CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Genome Editing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Genetic Engineering Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global gRNA Database/Gene Librar Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global CRISPR Plasmid Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Human Stem Cells Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Genetically Modified Organisms/Crops Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Cell Line Engineering Consumption and Growth Rate (2017-2022)

    • 9.2 Global CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Academic Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Research and Development Institutes Consumption and Growth Rate (2017-2022)

    10 Global CRISPR and CRISPR-associated (Cas) Genes Market Outlook by Types and Applications to 2028

    • 10.1 Global CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Genome Editing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Genetic Engineering Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global gRNA Database/Gene Librar Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global CRISPR Plasmid Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Human Stem Cells Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Genetically Modified Organisms/Crops Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Cell Line Engineering Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Research and Development Institutes Consumption Forecast and Growth Rate (2022-2028)

    11 Global CRISPR and CRISPR-associated (Cas) Genes Import and Export Analysis (Top 5 Countries)

    • 11.1 Global CRISPR and CRISPR-associated (Cas) Genes Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global CRISPR and CRISPR-associated (Cas) Genes Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 CRISPR and CRISPR-associated (Cas) Genes Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global CRISPR and CRISPR-associated (Cas) Genes Market Competitive Analysis

    • 14.1 Editas Medicine

      • 14.1.1 Editas Medicine Company Details

      • 14.1.2 Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.2 GE Healthcare Dharmacon

      • 14.2.1 GE Healthcare Dharmacon Company Details

      • 14.2.2 GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.3 Thermo Fisher Scientific

      • 14.3.1 Thermo Fisher Scientific Company Details

      • 14.3.2 Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.4 Caribou Biosciences

      • 14.4.1 Caribou Biosciences Company Details

      • 14.4.2 Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.5 CRISPR THERAPEUTICS

      • 14.5.1 CRISPR THERAPEUTICS Company Details

      • 14.5.2 CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.6 Mirus Bio LLC

      • 14.6.1 Mirus Bio LLC Company Details

      • 14.6.2 Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.7 Addgene

      • 14.7.1 Addgene Company Details

      • 14.7.2 Addgene CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Addgene CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.8 Takara Bio USA

      • 14.8.1 Takara Bio USA Company Details

      • 14.8.2 Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.9 Merck KGaA

      • 14.9.1 Merck KGaA Company Details

      • 14.9.2 Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.10 Horizon Discovery Group

      • 14.10.1 Horizon Discovery Group Company Details

      • 14.10.2 Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • 14.11 Intellia Therapeutics

      • 14.11.1 Intellia Therapeutics Company Details

      • 14.11.2 Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of CRISPR and CRISPR-associated (Cas) Genes

    • Figure CRISPR and CRISPR-associated (Cas) Genes Picture

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Consumption by Country (2017-2022)

    • Figure United States CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate (2017-2022)

    • Table Europe CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate (2017-2022)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate (2017-2022)

    • Figure Japan CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate (2017-2022)

    • Figure India CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate (2017-2022)

    • Figure South Korea CRISPR and CRISPR-associated (Cas) Genes Consumption and Growth Rate (2017-2022)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast by Country (2022-2028)

    • Figure United States CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure India CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea CRISPR and CRISPR-associated (Cas) Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genome Editing Consumption and Growth Rate (2017-2022)

    • Figure Global Genetic Engineering Consumption and Growth Rate (2017-2022)

    • Figure Global gRNA Database/Gene Librar Consumption and Growth Rate (2017-2022)

    • Figure Global CRISPR Plasmid Consumption and Growth Rate (2017-2022)

    • Figure Global Human Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Genetically Modified Organisms/Crops Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Line Engineering Consumption and Growth Rate (2017-2022)

    • Figure Global Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Academic Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Research and Development Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Genome Editing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genetic Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global gRNA Database/Gene Librar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CRISPR Plasmid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genetically Modified Organisms/Crops Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell Line Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research and Development Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Import by Region (Top 5 Countries) (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Export by Region (Top 5 Countries) (2017-2028)

    • Table Editas Medicine (Foundation Year, Company Profile and etc.)

    • Table Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table GE Healthcare Dharmacon (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Caribou Biosciences (Foundation Year, Company Profile and etc.)

    • Table Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table CRISPR THERAPEUTICS (Foundation Year, Company Profile and etc.)

    • Table CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Mirus Bio LLC (Foundation Year, Company Profile and etc.)

    • Table Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Addgene (Foundation Year, Company Profile and etc.)

    • Table Addgene CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addgene CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Takara Bio USA (Foundation Year, Company Profile and etc.)

    • Table Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Horizon Discovery Group (Foundation Year, Company Profile and etc.)

    • Table Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Product and Service

    • Table Intellia Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US